Public list: BIO 2016 (619) Smart Money VCs (6328) Pharma Startups (4734)
Innoviva, formerly known as Theravance, is focused on bringing compelling new medicines to patients in areas of unmet need by leveraging its significant expertise in the development, commercialization and financial management of bio-pharmaceuticals. ...Show all
Company (IPO / Went public)
Phone: 650-238-9600
2000 Sierra Point Parkway
Suite 500
Brisbane, 94005
California, United States
Total Funding | Date of Last Funding | |
---|---|---|
Innoviva | $257.7M | Oct 5, 2004 |
Cerecin | $247.9M | Oct 4, 2018 |
Inhibitex | $209.8M | Aug 12, 2005 |
See all 28 competitors |
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|